Evolent Health, Inc. (EVH) Income Statement Analysis

See more : Allin Corporation (ALLN) Income Statement Analysis – Financial Results

Complete financial analysis of Evolent Health, Inc. (EVH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Evolent Health, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.

You may be interested

Evolent Health, Inc. (EVH)

Industry: Medical - Healthcare Information Services

Sector: Healthcare

Website: https://www.evolenthealth.com

About Evolent Health, Inc.

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	1.96B	1.35B	907.96M	1.02B	846.38M	627.06M	434.95M	254.19M	96.88M	0.00	25.67M	8.35M
Cost of Revenue	1.50B	1.04B	657.55M	701.37M	513.06M	327.83M	269.35M	155.18M	57.40M	0.00	30.02M	11.27M
Gross Profit	460.47M	316.58M	250.41M	321.06M	333.32M	299.24M	165.60M	99.01M	39.48M	0.00	-4.35M	-2.93M
Gross Profit Ratio	23.45%	23.42%	27.58%	31.40%	39.38%	47.72%	38.07%	38.95%	40.75%	0.00%	-16.93%	-35.08%
Research & Development	0.00	27.00M	15.50M	15.10M	19.80M	18.20M	17.20M	11.10M	5.80M	0.00	2.00M	0.00
General & Administrative	0.00	0.00	219.50M	310.55M	392.82M	306.31M	205.67M	160.69M	75.29M	0.00	15.60M	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	358.11M	269.27M	219.50M	310.55M	392.82M	306.31M	205.67M	160.69M	75.29M	0.00	15.60M	15.98M
Other Expenses	173.57M	67.20M	60.04M	61.48M	60.91M	109.00K	171.00K	4.00K	7.17M	-25.25M	1.00K	0.00
Operating Expenses	531.68M	336.46M	279.54M	372.03M	453.73M	350.82M	238.04M	177.92M	82.45M	-25.25M	16.81M	16.69M
Cost & Expenses	2.04B	1.37B	937.09M	1.07B	966.79M	678.65M	507.39M	333.09M	139.85M	-25.25M	46.83M	27.96M
Interest Income	5.26M	1.37M	407.00K	3.16M	3.99M	3.44M	1.66M	0.00	0.00	0.00	0.00	18.00K
Interest Expense	54.21M	15.57M	25.43M	28.34M	14.53M	5.48M	3.64M	723.00K	293.00K	0.00	0.00	0.00
Depreciation & Amortization	123.42M	90.25M	60.04M	60.84M	66.64M	44.52M	32.37M	17.22M	7.17M	0.00	1.21M	114.00K
EBITDA	-24.79M	43.75M	55.66M	-241.38M	-245.95M	-4.15M	-40.40M	-220.31M	-31.51M	-25.25M	-20.35M	-19.51M
EBITDA Ratio	-1.26%	0.54%	9.94%	2.31%	-7.73%	-1.32%	-9.20%	38.10%	-464.44%	0.00%	-257.85%	-233.70%
Operating Income	-71.21M	-59.84M	30.25M	-37.88M	-120.41M	-47.48M	-72.84M	-237.42M	-42.97M	-25.25M	-21.16M	-19.62M
Operating Income Ratio	-3.63%	-4.43%	3.33%	-3.71%	-14.23%	-7.57%	-16.75%	-93.40%	-44.36%	0.00%	-82.41%	-235.07%
Total Other Income/Expenses	-131.19M	-65.72M	12.61M	-67.69M	-18.23M	-6.67M	-3.56M	-114.00K	386.26M	-25.25M	41.19M	19.00K
Income Before Tax	-202.41M	-62.08M	-29.80M	-337.80M	-327.12M	-54.15M	-76.40M	-237.53M	343.29M	-25.25M	20.03M	-19.60M
Income Before Tax Ratio	-10.31%	-4.59%	-3.28%	-33.04%	-38.65%	-8.64%	-17.57%	-93.45%	354.35%	0.00%	78.03%	-234.84%
Income Tax Expense	-89.37M	-43.38M	483.00K	-3.55M	-21.54M	40.00K	-6.64M	-10.76M	23.48M	0.00	8.00K	337.00K
Net Income	-113.04M	-18.70M	-30.28M	-334.25M	-305.58M	-52.66M	-60.67M	-159.74M	332.49M	-25.25M	20.02M	-19.26M
Net Income Ratio	-5.76%	-1.38%	-3.34%	-32.69%	-36.10%	-8.40%	-13.95%	-62.84%	343.21%	0.00%	78.00%	-230.81%
EPS	-1.28	-0.20	-0.35	-3.94	-3.71	-0.68	-0.94	-3.55	13.14	-0.66	0.06	-1.13K
EPS Diluted	-1.28	-0.20	-0.35	-3.94	-3.71	-0.68	-0.94	-3.55	6.93	-0.66	0.06	-1.13K
Weighted Avg Shares Out	111.25M	93.70M	86.07M	84.93M	82.36M	77.34M	64.35M	45.00M	25.13M	38.23M	38.23M	17.00K
Weighted Avg Shares Out (Dil)	111.25M	93.70M	86.07M	84.93M	82.36M	77.34M	64.35M	45.03M	46.14M	38.23M	38.23M	17.00K

What Makes Evolent Health (EVH) a Good Fit for "Trend Investing"

July 20, 2022zacks.com

Evolent Health (EVH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Dave & Busters, USA Truck See Activist Investor Action

July 15, 2022marketwatch.com

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

Has Evolent Health (EVH) Outpaced Other Computer and Technology Stocks This Year?

July 14, 2022zacks.com

Here is how Evolent Health (EVH) and KT Corp. (KT) have performed compared to their sector so far this year.

Shareholder Alert - The M&A Class Action Firm Announces an Investigation of Evolent Health, Inc. - EVH

June 30, 2022prnewswire.com

NEW YORK , June 30, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class...

Evolent Health: Healthy Growth, But That Is About It

June 30, 2022seekingalpha.com

Evolent Health is a so-called value-based care provider, aiding payers and patients. The segment shows resilient growth, including Evolent, as no real profitability has been reported.

Why Evolent Health Stock Crept Higher Today

June 29, 2022fool.com

Investors had a muted, yet positive, reaction to news of the company's latest acquisition.

EVOLENT HEALTH TO ACQUIRE IPG

June 29, 2022prnewswire.com

- Expected to Accelerate Evolent Health's Position as a Leading Provider of Value-Based Specialty Care Solutions - Expands Evolent's Value-Based Specialty Care Solutions Portfolio to Musculoskeletal Conditions - Expected to be Immediately Accretive to Adjusted EBITDA Margins and Cash Flow...

Evolent Health (EVH) is on the Move, Here's Why the Trend Could be Sustainable

June 28, 2022zacks.com

Evolent Health (EVH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Evolent Health, Inc.

May 27, 2022newsfilecorp.com

Wilmington, Delaware--(Newsfile Corp. - May 27, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Evolent Health, Inc. (NYSE: EVH) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-evolent-health-inc.To...